External cervical resorption may occur in patients with MOG antibody-associated disease, which is clearly detected on cone-beam computed tomography. Therefore, dental screening is essential for these patients before initiating bisphosphonate therapy. Larger sample sizes are crucial to determine any possible association between external cervical resorption and MOG antibody-associated disease.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259924 | PMC |
http://dx.doi.org/10.1002/ccr3.4415 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!